A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
The Hospital Clínic Barcelona-IDIBAPS, together with the Hospital Sant Joan de Déu in Barcelona, is participating in the CrinGenES project, a pioneer1
The Molecular Biology CORE Operational Area at the Hospital Clínic incorporates the most sophisticated genome sequencer currently available on the ma1
Last year, the Hospital Clínic Barcelona treated 2,384 cases of intoxication. They represent 2.2% of the total number of cases treated in the A&E Dep1
Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regulat1
Hospital Clínic Barcelona-IDIBAPS and the European Foundation for the Study of Chronic Liver Failure (EF CLIF) have renewed their framework collabora1
A study jointly led by the Hospital Clínic-IDIBAPS and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening i1
With the arrival of the mushroom season, many enthusiasts take to the woods to hunt for them. However, it is essential to follow certain guidelines i1
The Committee for the Evaluation of Medicinal Products for Human Use of the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved ARI01
The centre becomes the first in Spain to use blood biomarker p-tau217, which offers a more accurate and less invasive diagnosis and marks a paradigm1